Inspiratory breathing movements depend on pre-Bö tzinger complex (preBö tC) interneurons that express calcium (Ca 2+ )-activated nonselective cationic current (I CAN ) to generate robust neural bursts. Hypothesized to be rhythmogenic, reducing I CAN is predicted to slow down or stop breathing; its contributions to motor pattern would be reflected in the magnitude of movements (output). We tested the role(s) of I CAN using reverse genetic techniques to diminish its putative ion channels Trpm4 or Trpc3 in preBö tC neurons in vivo. Adult mice transduced with Trpm4-targeted short hairpin RNA (shRNA) progressively decreased the tidal volume of breaths yet surprisingly increased breathing frequency, often followed by gasping and fatal respiratory failure. Mice transduced with Trpc3-targeted shRNA survived with no changes in breathing. Patch-clamp and field recordings from the preBö tC in mouse slices also showed an increase in the frequency and a decrease in the magnitude of pre-Bö tC neural bursts in the presence of Trpm4 antagonist 9-phenanthrol, whereas the Trpc3 antagonist pyrazole-3 (pyr-3) showed inconsistent effects on magnitude and no effect on frequency. These data suggest that Trpm4 mediates I CAN , whose influence on frequency contradicts a direct role in rhythm generation. We conclude that Trpm4-mediated I CAN is indispensable for motor output but not the rhythmogenic core mechanism of the breathing central pattern generator.
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Introduction
Inspiratory breathing movements in mammals emanate from neural rhythms of the pre-Böt-zinger complex (preBötC) in the lower brainstem [1] [2] [3] [4] . If preBötC excitability is sufficiently high, then its constituent interneurons burst synchronously and drive motor output [5, 6] . Calcium (Ca 2+ )-activated nonselective cation current (I CAN ) may play a substantial role by generating the depolarization underlying inspiratory bursts, i.e., the inspiratory drive potential [7, 8] . I CAN -mediated inspiratory drive potentials are evoked by excitatory synaptic inputs and intrinsic Ca 2+ signaling in the context of rhythmic network activity [7] [8] [9] [10] [11] [12] , but whether inherently part of rhythmogenesis or effectuating motor pattern, the role(s) of I CAN remain incompletely understood.
The ion channels that give rise to I CAN have not been identified, but transient receptor potential (Trp) channels are likely candidates. There are 28 different Trp subtypes, subdivided into seven subfamilies, which broadly share structural similarity but vary in their permeability to mono-and divalent cations as well as their activation mechanisms. Widely expressed in the nervous system, Trp channels mediate phototransduction, thermosensation, gustation, nociception, and a range of homeostatic functions [13] [14] [15] [16] .
A limited subset of Trps from the Trpm (M for melastatin) and Trpc (C for canonical) subfamilies are implicated in respiration. We originally posited that either Trpm4 or Trpm5 (or both) gave rise to I CAN in the preBötC [8, 17] because they form flufenamic acid (FFA)-sensitive 24-picosiemens (pS) conductance monovalent cation channels, which are gated by intracellular Ca 2+ transients and modulated by phosphoinositides [18] [19] [20] . However, 24-pS ion channel activity recorded in sync with fictive inspiration in preBötC neurons is sensitive to ATP −4 [21, 22] . Trpm4, but not Trpm5, is sensitive to blockade by highly charged polyatomic anions like ATP −4 [23] [24] [25] [26] , which is only consistent with Trpm4 in the preBötC. As further confirmation that Trpm4, rather than Trpm5, is involved with respiratory rhythm and pattern, we recently showed that Trpm4, but not Trpm5, transcripts are expressed in excitatory preBötC neurons [27] . Trpc3 forms 23-pS conductance ion channels permeable to mono-and divalent cations [28, 29] , which seems inconsistent with the Ca 2+ -activated monovalent intrinsic current I CAN . Nevertheless, the heteromeric association of Trpc3 with Trpc1 markedly reduces Ca 2+ permeability [30] , and Trpc1 transcripts are expressed at approximately the same level as Trpm4 in the preBötC [27] , so a heteromeric Trpc3-mediated monovalent I CAN is feasible. Trpc3 has already been implicated in regulation of respiratory rhythm [31] . Furthermore, RNA sequencing (RNA-seq) revealed Trpc3 to be the single most abundantly expressed Trp gene in rhythmogenic and nonrhythmogenic preBötC neurons [27] , so it rises to the top of candidates from the Trpc family as an ion channel subunit that could mediate or contribute to I CAN . Excitatory interneurons that form the inspiratory core oscillator in the preBötC are derived from precursors expressing the transcription factor developing brain homeobox 1 (Dbx1) [32] [33] [34] [35] [36] [37] . A subset of Dbx1-derived neurons also shapes motor output pattern [38, 39] . Whether for rhythm or pattern generation, Dbx1-derived neurons express I CAN [33, 40] . Neighboring nonDbx1-derived interneurons, presumably inhibitory, influence breathing motor pattern and inspiratory-expiratory phase transition [41] [42] [43] [44] , so I CAN , which is ubiquitous in the preBötC [8] , is relevant to their role(s) as well. Therefore, we evaluated the breathing-related role(s) of Trpm4 and Trpc3 as two likely candidates underlying I CAN in preBötC neurons. Attenuating the activity of Trpm4, but much less so Trpc3, affects breathing behavior by attenuating motor output functions of the preBötC but not rhythm generation per se. Koizumi and colleagues reach a similar conclusion using an in vitro approach [45] . We propose that Trpm4 largely mediates I CAN , which forms a part of the pattern generator microcircuit rather than the core oscillator for breathing.
Results

Trpm4 and Trpc3 ion channels in preBötC interneurons
For reasons outlined in the Introduction, we considered Trpm4 or Trpc3 (or both) to be likely candidates that mediate I CAN . Having sequenced the transcriptome of Dbx1 and non-Dbx1 preBötC neurons [27] and released those data in the public domain (National Center for Biotechnology Information [NCBI] Gene Expression Omnibus database, accession no. GSE100356), here, we rank-ordered Trp transcripts according to expression level. Sixteen out of 28 Trp genes showed nonzero expression in the preBötC (Fig 1) . Trpc3 had the highest level of expression (reads per kilobase of transcript per million mapped reads [RPKM] 18.5 in Dbx1 neurons, 11.9 in non-Dbx1 neurons). Trpm4 expression (RPKM 0.9 in Dbx1 neurons, 1.0 in non-Dbx1 neurons) was below the median RPKM for all expressed genes (1.7, [27] ), but Trpm4 expression was in the top half of all Trp channel genes and, for reasons outlined in the Introduction, was a strong candidate a priori for I CAN . Other Trp channels among the 16 we detected are unlikely to give rise to I CAN for the following reasons. Trpm2, Trpm3, Trpm8, and Trpv2 are thermosensitive; Trpc1, Trpc4, Trpc5, and Trpc7 form store-operated channels (SOC); and Trpm7 and Trpv6 are primarily divalent ion channels [14, 16] . Finally, the singlechannel conductance of Trpp2 and Trpp5 exceed 100 pS [46] , which is incompatible with 24-pS channel activity in sync with inspiration in preBötC neurons [21] .
Having quantified Trpm4 and Trpc3 transcripts in Dbx1 (excitatory) and non-Dbx1 (presumably inhibitory) preBötC neurons through RNA-seq, we examined expression of these genes at the protein level via immunohistochemical labeling. In adult and neonatal mice, we detected Trpm4 (Figs 2 and S1) and Trpc3 (Figs 3 and S2) in both Dbx1-derived and nonDbx1-derived preBötC interneurons, which suggests that these channels could comprise I CAN and thus be relevant to breathing in adult as well as perinatal mice. Dbx1-derived cells in the preBötC include astrocytes [32, 38, 47] , which did not express Trpm4 (Fig 2D) or Trpc3 (Fig 3C) .
shRNA knockdown of Trpm4 and Trpc3 affect breathing behavior
We used short hairpin RNA (shRNA) to knock down Trp channels in adult mice. Adeno-associated viruses (AAVs) encoding either a Trpm4-or Trpc3-targeted shRNA (hereafter referred to as Trpm4 or Trpc3 shRNA) as well as enhanced green fluorescent protein (eGFP) were injected in the preBötC. First, we injected shRNA unilaterally into the left preBötC in conjunction with contralateral (right side) injections of a nontargeting control sequence (n = 6 mice total). Five weeks later, Trpm4 and Trpc3 expression were 72% ± 3% and 76% ± 4% lower, respectively, in the left preBötC compared to the right preBötC, which shows that shRNAs effectively impede Trp ion channel gene expression in preBötC neurons (Table 1) .
We next assessed the time course of Trp channel knockdown by injecting another cohort of mice with shRNA and then measuring Trpm4 and Trpc3 protein expression in the preBötC over time (n = 12 mice injected with Trpm4 shRNA and n = 12 mice injected with Trpc3 shRNA). Western blots quantifying protein expression showed a monotonic decline in Trpm4 and Trpc3 ion channel expression as a function of number of days postinjection. Trpm4 was reduced by 12%, 42%, 62%, and 65% and Trpc3 was reduced by 33%, 38%, 52%, and 68% at days 10, 20, 30, and 40, respectively (S3 Fig). Trpm4 shRNA. We measured breathing behavior intermittently in 11 awake adult mice for six weeks following bilateral injection of Trpm4 shRNA. Fig 4 shows typical preinjection behavior with bouts of eupnea (i.e., calm breathing), exploratory movements, grooming, and one sigh highlighted in gray (also shown in the inset at higher sweep speed). Baseline measurements of eupnea include tidal volume (V T ) of 0.2 ± 0.04 ml, breathing frequency of 4.4 ± 1.2 Hz, inspiratory time (T I ) of 161 ± 50 ms, and minute ventilation (MV) of 0.05 ± 0.01 l/min. The average baseline sigh frequency measured 0.60 ± 0.12 min Mice injected with Trpm4 shRNA showed a progressive diminution of V T and T I , combined with an increase in frequency (Fig 5A) . These changes were pathological. After day 13 of the observation period, six out of 11 animals were gasping at rates exceeding 0.2 min −1 (max rate 10.1 min
, mean ± SD measured 1.5 ± 3.3 min
) in normoxia, which was never observed in baseline conditions or prior to day 13 postinjection (Fig 5B tallies gasps in the cohort) . Five out of the 11 animals apparently died of respiratory failure after 21-37 days (Fig 5C) . In each case, we confirmed the expression of eGFP, i.e., Trpm4 shRNA, in the preBötC as well as the paucity of eGFP in adjacent respiratory sites, including the rostrally located Bötzinger complex of the medulla and the ventral respiratory group of the upper cervical spinal cord (S4 Fig). We applied a linear regression model to analyze how Trpm4 shRNA affected breathing measurements over time (Fig 6) . The slope of V T versus day post-shRNA was significantly nonzero (Fig 6, 1st row, cyan, r 2 = 0.12, P = 1E-5), emphasizing a significant progressive diminution of V T during the observation period. V T decreased 31% to 0.13 ± 0.03 ml by the endpoint of the experiment (n = 11). Note that endpoint V T was computed using either the V T at the end of 6 weeks (n = 6) or on the last measurement day prior to death (n = 5). The slope of T I versus day post-shRNA was also significantly nonzero (Fig 6, 2nd row, cyan, r 2 = 0.2, P = 4E-8). The endpoint T I decreased 28% to 111 ± 37 ms (n = 11). The slope of frequency versus day post-shRNA was significantly nonzero (Fig 6, 3rd row, cyan, r 2 = 0.14, P = 1.2E-6); in this case, slope was positive. The endpoint frequency increased 35% to 5.6 ± 1.9 Hz (n = 11). In contrast, MV did not change during the observation period because decreases in breath magnitude, quantified by V T and T I , were counterbalanced by frequency increases ( Fig 6, 4th row, i.e., the slope of MV versus day post-shRNA was ostensibly zero, r 2 = 0.004, P = 0.5). The endpoint MV measured 0.05 ± 0.02 l/min (n = 11). Sigh frequency significantly decreased following Trpm4 shRNA; by the endpoint, it was 30% lower, 0.42 ± 0.18 min magenta; V T : r 2 = 0.07, P = 0.001; T I : r 2 = 0.04, P = 0.02). The endpoint V T decreased by 13% to 0.21 ± 0.03 ml, and the endpoint T I decreased by 14% to 132 ± 56 ms. However, the low values of r 2 (0.07 and 0.04, respectively) and the small total changes in V T and T I (13% and 14%, respectively) diminish the physiological significance of these results, even though they pass the threshold for statistical significance. The changes in V T and T I were less substantial in Trpc3 shRNA-injected mice compared to Trpm4 shRNA-injected mice: a 13% versus 31% decrease in V T and a 14% versus 28% decrease in T I , respectively. Frequency did not change as a function of day post-shRNA ( Fig 6, 3rd row, magenta, r 2 = 0.03, P = 0.06); its endpoint measured 4.9 ± 1.1 Hz. Neither did MV change during the observation period (Fig 6, 4th row, magenta, r 2 = 0.003, P = 0.5). Endpoint MV measured 0.06 ± 0.01 l/min. Sigh frequency was also unchanged, measuring 0.60 ± 0.18 min −1 (P = 0.37) at the endpoint. Four of the seven Trpc3 shRNA-injected mice gasped at rates exceeding 0.2 min −1 at some point during the observation period, but the tally of gasps in this cohort never exceeded 23, whereas the gasp tally in Trpm4 shRNA-injected mice exceeded 300 after 30 days of observation ( Fig 5B) . All seven Trpc3 shRNA-injected mice were alive after 6 weeks. Nontargeting shRNA. Baseline measurements of eupnea for nontargeting control shRNA-injected mice (n = 8) include V T of 0.22 ± 0.05 ml, frequency of 3.8 ± 1.4 Hz, T I of 209 ± 102 ms, and MV of 0.05 ± 0.02 l/min. The average baseline sigh frequency measured 0.54 ± 0.48 min
Mice injected with nontargeting shRNA (n = 8) showed no changes in V T , frequency, MV, or sigh frequency during the observation period. V T measured 0.21 ± 0.03 ml, frequency measured 4.3 ± 0.7 Hz, and MV measured 0.05 ± 0.01 l/min at the endpoint (Fig 6, 1st, 3rd , and 4th rows, gray; V T : r 2 = 0.005, P = 0.4; frequency: r 2 = 0.025, P = 0.053; MV: r 2 = 0.01, P = 0.2).
Sigh frequency measured 0.47 ± 0.12 min −1 (P = 0.27) at the endpoint.
We observed a significantly nonzero slope of T I versus day post-shRNA ( Fig 6, 2nd row, gray, r 2 = 0.05, P = 0.005). T I measured 160 ± 33 ms at the endpoint, a 23% decrease that we conclude is not physiologically meaningful because there was no corresponding change in V T .
No control animals gasped at any stage and all eight mice were alive 6 weeks after shRNA injection.
Trpm4 and Trpc3 influence preBötC bursts and rhythm in vitro
preBötC field recordings. We tested the effect of the Trpm4 antagonist 9-phenanthrol and Trpc3 antagonist pyrazole-3 (pyr-3) (in separate experiments) on the magnitude of rhythmic preBötC field potentials in a slice model of breathing. The preBötC in vitro generates eupnea-related inspiratory bursts, which typically occur at approximately 0.2 Hz, as well as larger magnitude sigh-related bursts that occur at 0.3-0.6 min −1 and for which each sigh burst is followed by a prolonged pause [48, 49] . The half-maximal effective concentration (EC 50 ) for 9-phenanthrol in the preBötC measured 32 µM (S5 Fig), and it is typically applied to excitable cells at a dose of 100 µM [50] . Exposing slices to 9-phenanthrol significantly reduced the area of the preBötC inspiratory bursts by 42% (P = 4E-7) and sigh bursts by 39% (P = 4E-6), with a injected with Trpm4 (cyan), Trpc3 (magenta), and nontargeting control (gray) shRNA. Elapsed time following shRNA injection was binned in 6-day increments. Primary data can be found in the Supporting information (S1 Data 26% increase in inspiratory frequency (P = 0.006) (Fig 7A-7E , all n = 14) but no significant change in sigh frequency (P = 0.9). These data suggest that Trpm4 influences inspiratory and sigh burst area in the preBötC and, further, that Trpm4 attenuation increases inspiratory frequency, but not sigh frequency, in vitro. We could not determine the EC 50 for pyr-3 in the preBötC because of its inconsistent effects on respiratory network activity in vitro (S5 Fig). Therefore, we applied pyr-3 at 10 μM, consistent with the biophysics literature [51, 52] . Pyr-3 had no effect on any measurement; neither the area nor the frequency of preBötC inspiratory (n = 5) and sigh (n = 4) bursts registered any change (Fig 7F-7J , inspiratory bursts [P = 0.1], sigh bursts [P = 0.7], inspiratory frequency [P = 0.3], sigh frequency [P = 0.4]). These data suggest that Trpc3 has little influence on inspiratory or sigh burst generation considering collective activity among all preBötC neurons and that Trpc3 does not influence the frequency of inspiration or sighs in vitro.
Whole-cell recordings from Dbx1 preBötC neurons. Next, we evaluated the Trpm4 and Trpc3 contributions to I CAN -mediated inspiratory drive potentials and sigh bursts via individual Dbx1 preBötC neuron recordings in brainstem slices. We employed (whenever possible) intracellular pharmacology applied via the patch pipette to avoid network effects of the ion channel antagonists, which, if bath-applied, could diminish endogenous rhythmic drive to preBötC neurons and impact frequency (this concern pertains to 9-phenanthrol, given the network effects on burst area and frequency quantified in Fig 7) . Control whole-cell recordings (without drug dialysis) exhibited no change in the amplitude of inspiratory drive potentials (n = 7) or sigh bursts (n = 5) during 40 min of continuous recording (Figs 8A and S6; inspiratory bursts P = 0.06, sigh bursts P = 0.09). Therefore, drug-induced changes in subsequent experiments cannot be attributed to rundown. Inspiratory drive potentials were attenuated by 49% ± 13% following whole-cell dialysis of (1,2-bis(2-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid) (BAPTA) (Figs 8B and S6, P = 0.01, n = 5), which precludes I CAN activation, and by 64% ± 16% following whole-cell dialysis of the general I CAN antagonist FFA (Figs 8C and S6; P = 0.002, n = 6). Similarly, the amplitude of sigh bursts decreased 31% ± 17% in the presence of BAPTA (Figs 8B and S6; P = 0.03, n = 5) and decreased 33% ± 13% in the presence of FFA (Figs 8C and S6; P = 0.02, n = 4). These data re-emphasize that I CAN contributes substantially to inspiratory bursts and further show that I CAN contributes to sigh bursts, which has not been previously demonstrated. Intracellular dialysis of the Trpm4 antagonist 9-phenanthrol reduced the amplitude of inspiratory drive potentials by 28% ± 19% (P = 0.008, n = 13) and sigh bursts by 12% ± 12% (Figs 8D and S6, P = 0.027, n = 9). These data indicate that Trpm4 contributes to I CAN , as measured in field recordings and whole-cell recordings of Dbx1 preBötC neurons.
Pyr-3 is not effective when applied intracellularly [51] so that drug was added to the bath, which reduced the amplitude of inspiratory drive potentials by 26% ± 22% (P = 0.02, n = 10) and sigh bursts by 22% ± 13% (Figs 8E and S6; P = 0.009, n = 7). These data show that Trpc3 also influences the magnitude of inspiratory and sigh bursts in Dbx1-derived preBötC neurons and thus could contribute to I CAN in core preBötC neurons.
9-phenanthrol had the same effect in field and Dbx1 whole-cell recordings, i.e., it diminished inspiratory and sigh bursts, but pyr-3 did not; it reduced inspiratory and sigh bursts in Dbx1 whole-cell recordings but not in preBötC field recordings. To examine a cellular basis for this disparity, we tested how Trp channel antagonists affect inhibitory (glycinergic) preBötC neurons visualized using mice that express eGFP under the control of the promotor of the glycine transporter 2 (GlyT2) gene, that is, GlyT2-eGFP mice [53] . Neither 9-phenanthrol nor pyr-3 had any measurable effect on inspiratory or sigh bursts (S7 Fig). Roughly equally divided into excitatory (Dbx1) and inhibitory (principally glycinergic [41, 54] ) interneurons, the negligible effect of pyr-3 in preBötC field recordings (Fig 7F-7J ) could be attributed to its lack of effect in the population of glycinergic preBötC interneurons (S7 Fig). 
Discussion
In air-breathing mammals, humans among them, inspiration is the foremost motor phase that organizes the breathing cycle. It emerges from a network oscillator in the brainstem preBötC wherein excitatory synaptic interactions are rhythmogenic [1, 3, 55] . However, the role of cellular burst-generating intrinsic currents remains unresolved.
preBötC activity typically culminates with a robust inspiratory burst, whose underlying drive potential of 20-40 mV amplitude depends on synaptically evoked I CAN [8, 11, 12, 21, 56] . Although it has previously been considered an integral part of the rhythm-generating mechanism [57, 58] , our data instead show that I CAN , mediated by Trpm4 (and possibly Trpc3 and other) ion channels, selectively influences the magnitude of preBötC output and breath size, and thus, its role pertains to the first stage of motor pattern generation rather than rhythmogenesis per se.
Trpm4 mediates I CAN in preBötC interneurons
Whereas 16 of 28 Trp channel genes are expressed in the preBötC, we favor Trpm4 as one major contributor to I CAN ; Trpc3 appears to contribute as well. The other 14 Trps may give rise to ion channels that modulate preBötC activity or underlie cell signaling pathways but, for reasons argued above (see Results: Trpm4 and Trpc3 ion channels in preBötC neurons), are unlikely to mediate I CAN , whose phasic activation coincides with (probably to amplify) inspiration and sighs.
I CAN was originally attributed to Trpm4 and Trpm5 because of their similar gating mechanisms, 24-pS single-channel conductance, phosphoinositide modulation, and pharmacology [8, 25] . However, we can now rule out Trpm5 entirely because inspiratory phasic ion channel activity in preBötC neurons is ATP sensitive [21, 22] , which is a uniquely Trpm4 property [23] [24] [25] [26] , and no Trpm5 transcripts are detectable in preBötC neurons (Fig 1 and [27] ). Prior reports of Trpm5 in the preBötC [9, 17] may reflect its expression in laryngeal motoneurons or preganglionic autonomic neurons of the nucleus ambiguus [59] , which adjoin and partially overlap with the preBötC, as well as in non-neural tissues.
Trpc3 ion channels may also contribute to preBötC I CAN , given the preeminent expression level of Trpc3 transcripts in Dbx1 and non-Dbx1 neurons (Fig 1 and [27] ), 23-pS single-channel conductance [29, 60] , and phosphoinositide modulation [20, 61, 62] . However, Trpc3 Ca 2+ permeability exceeds that of monovalent cations, i.e., P Ca /P Na > 1 [14, 16, 46, 63] Among these two channels, Trpm4 is predominant because the breathing phenotype was far stronger, and often fatal, in Trpm4 shRNA-compared to Trpc3 shRNA-injected mice. In vitro, preBötC field recordings only implicate Trpm4 because its antagonist 9-phenanthrol diminished preBötC inspiratory and sigh bursts, whereas the Trpc3 antagonist pyr-3 did not. Nevertheless, in Dbx1 preBötC neurons, both Trpm4 and Trpc3 contributed to inspiratory and sigh bursts; pyr-3 and 9-phenanthrol nearly equivalently diminished inspiratory bursts, and pyr-3 reduced sigh bursts more than 9-phenanthrol. At face value, those data suggest that Trpc3 and Trpm4 contribute commensurately to burst generation in Dbx1 preBötC neurons, but we argue that because pyr-3 had to be bath-applied during whole-cell recordings, its effects were magnified by impacting all constituent Dbx1 neurons whose collective synaptic drive would have been diminished. 9-phenanthrol, by contrast, acted only through the patch pipette of the neuron being recorded, so network synaptic drive would not have been affected. Therefore, one cannot compare the relative pharmacological attenuation of drive potentials recorded in whole-cell conditions to reach a conclusion about which ion channel predominantly comprises I CAN ; instead, we rely on the field recordings in vitro and shRNA experiments in vivo to evaluate their relative contributions.
We conclude that Trpm4 is the predominant ion channel underlying I CAN , a ubiquitous current in preBötC neurons. In Dbx1-derived preBötC neurons specifically, Trpm4 and Trpc3 may constitute I CAN , probably via separate ion channel populations, but the contribution of Trpm4 exceeds that of Trpc3.
preBö tC Trp channels govern breathing pattern I CAN is not rhythmogenic but critical for motor pattern Slices that include the preBötC and hypoglossal nerve root (XII) nucleus retain the minimal microcircuit to generate fictive inspiration and sighs and thus are experimentally advantageous for studies of rhythm and pattern generation [72] [73] [74] [75] . A rhythmogenesis model we promoted [58] posits that recurrent excitation triggers I CAN to produce robust inspiratory bursts. That model predicts that I CAN attenuation should either slow down the rhythm-because it would take longer for recurrent excitation to build up the inward currents needed to generate inspiratory bursts-or stop the rhythm entirely if recurrent excitation is insufficient to culminate the respiratory cycle. However, rhythms in vitro sped up after blocking Trpm4 (and did not change after blocking Trpc3). We conclude that I CAN is not rhythmogenic, but what can explain the counterintuitive frequency increase? Inspiratory cycles in vitro are unconstrained by phasic synaptic inhibition from pulmonary stretch receptors in the periphery that ordinarily truncate inspiration and thus cut down on cycle time and increase frequency [42, 43] . Removing that sensory feedback amplifies inspiratory bursts, which are followed by a pronounced refractory period that depresses frequency [42, 76] . (Temperature differences also influence frequencies in vivo versus in vitro, but we refer the reader to [77] and instead focus on intrinsic and synaptic factors.) Here, pharmacological attenuation of Trpm4-dominated I CAN also truncates inspiratory bursts, which produces the same net effect as sensorimotor feedback inhibition in vivo, namely increasing frequency.
Regarding pattern, I CAN attenuation reduced drive potentials in Dbx1 preBötC neurons (which reflects Trpm4 and Trpc3 contributions). Trpm4-dominated I CAN attenuation reduced preBötC field potentials for inspiration and sighs. Therefore, I CAN is relevant because it governs preBötC burst magnitude and thus the ability to propagate inspiratory phase activity (and sighs) to premotor neurons and drive motor output. Our data and conclusions regarding inspiratory burst magnitude complement a recent report by Koizumi and colleagues [45] , but we uniquely report the role of I CAN in sighs in vitro.
We additionally knocked down Trpm4 and Trpc3 expression in the adult mouse preBötC. Attenuation of Trpm4-dominated I CAN progressively decreased breath size (V T and T I )-which is consistent with its role governing motor pattern identified in vitro-but also increased breathing frequency. That frequency effect in vivo may be partly attributable to decreasing the refractory period following inspiration in core preBötC neurons, as explained above. A more important factor may be that sentient mice with intact chemosensory feedback increased their breathing rate, either via increased respiratory drive or volitionally, because smaller breaths induced by channel knockdown-at the original frequency-were insufficient to meet oxygen demand. Recall that MV (the product of V T and frequency) did not change prior to gasping and/or death, so the Trpm4 shRNA-injected mice were able to sustain ventilation via this compensatory mechanism for approximately 22 days.
Whereas inspiratory frequency increased following Trpm4 shRNA, we note that sigh rate decreased, and that may have further contributed to respiratory insufficiency by gradually diminishing the gas exchange surface area of the alveoli [1, 74] .
An increase in fictive (inspiratory) breathing frequency was also observed in brainstem-spinal cord preparations in situ following bath application of the Trpm4 antagonist 9-phenanthrol [45] . That frequency effect in situ is attributable (at least in part) to a different mechanism involving inhibitory microcircuits unrelated to sensorimotor integration, and extrinsic to the preBötC, that interact with preBötC excitatory microcircuits [42, 78] . Those inhibitory circuits are excluded from slices but retained in in situ preparations. Trpm4 channels are expressed throughout the medulla and bath-applied 9-phenanthrol acts on the medulla in its entirety. Therefore, as 9-phenanthrol reduces postinspiration (i.e., the inspiratory-expiratory phase transition), it increases the inspiratory frequency in situ partly because of effects on inhibitory interneurons distributed throughout the medulla [45] . Whether Trpm4 channels are expressed specifically in the postinspiratory complex (PiCo, [79] ) is not yet known, so PiCo-related contributions to frequency control in the Koizumi and colleagues [45] pharmacological experiments in situ cannot yet be evaluated. Here, we limited shRNA injection to the preBötC so the inhibitory microcircuits that govern postinspiration and inspiratory-expiratory phase transition, predominantly in the rostral medulla [42, [79] [80] [81] , would not be affected in our experiments in vivo.
Regarding motor output, inspiratory rhythm propagates caudally from the preBötC to phrenic premotor neurons of the rostral ventral respiratory group (rVRG) [39, [82] [83] [84] 
It is similarly unlikely that Trpm4 shRNA affected respiratory interneurons of the rostrally sited Bötzinger complex based on the low eGFP expression observed in that region. Nevertheless, because Bötzinger neurons are inhibitory [85] [86] [87] [88] [89] , if Trpm4 shRNA had expressed there, it would disinhibit phrenic premotor neurons and phrenic motor neurons and thus probably augment the drive to the breathing pump rather than diminish it.
We observed eGFP expression dorsal to the preBötC, where airway premotor neurons and laryngeal motoneurons are located [38, [90] [91] [92] [93] [94] . Therefore, Trpm4 knockdown could have affected airway patency but those airway effects would not impact tidal volume or inspiratory time, which are instead controlled by inspiratory pump musculature (e.g., diaphragm, external intercostals).
Attenuating Trpc3 (minimally) reduced breath size in vivo and in inspiratory drive potentials in Dbx1 preBötC neurons but did not affect preBötC field recordings. Only 35% of inhibitory (non-Dbx1) preBötC neurons express Trpc3 [45] . Furthermore, we measured no attenuation of inspiratory or sigh bursts in glycinergic preBötC neurons. Therefore, we conclude that inhibitory preBötC interneurons maintain inspiratory and sigh burst discharge behavior in pyr-3, which sustains the overall magnitude of preBötC field potentials even as drive potentials decrease in the Dbx1 preBötC subpopulation. While the activity of inhibitory interneurons affects phasic activity of respiratory microcircuits and sensorimotor integration [41, 42, 78, 95] , uniquely Dbx1-derived excitatory neurons of the preBötC and rVRG generate rhythm and drive phrenic premotor neurons [39] and thus directly impact inspiratory breathing movements, which includes sighs.
Koizumi and colleagues [45] reported a decrease in XII motor output and an increase in frequency (in some preparations, e.g., their Fig 4B, left) . However, they applied pyr-3 at 50 μM, which exceeds the EC 50 by 10-fold, so off-target effects on preBötC and XII motoneurons might be partly responsible. We also found that pyr-3 concentrations exceeding 10 μM diminished XII output and increased frequency (see S5 Fig) , whereas there was no change in the XII output or frequency in response to 10 μM pyr-3, which still exceeds the EC 50 [51, 52] .
A factor we cannot quantify is the extent to which the preBötC and ventral respiratory microcircuits compensate during the observation period to recover inspiratory and sigh burstgenerating function in the face of Trpm4 (or Trpc3) knockdown [96] . Considering Trpm4 shRNA, which exerted the strongest effect, the cumulative effect of any compensatory changes were insufficient to rescue breathing: the effects on breath magnitude and frequency were comparable to acute effects of 9-phenanthrol in vitro from our data and those of Koizumi and colleagues [45] .
Trpm4-mediated I CAN contributes to breathing predominantly in Dbx1 preBötC neurons
The preBötC contains roughly half excitatory neurons (Dbx1-derived) and half inhibitory neurons [41, 54, 97, 98] , but the shRNA does not discriminate neuron types. Dbx1 preBötC neurons are central for respiratory rhythm and motor output pattern in adult [34,35,37,99] and neonatal mice [32,33,36], so attenuating their activity would be expected to impact breathing. However, could Trpm4 knockdown in non-Dbx1 neurons explain, at least in part, the breathing phenotype here?
If Trpm4 shRNA reduced inspiratory burst magnitude in non-Dbx1 (presumably) inhibitory preBötC neurons, then it would increase (not decrease) breath size because it has been repeatedly demonstrated that disinhibition of the preBötC enhances breath size [41-43]. If we had observed an increase in breath size following Trpm4 (or Trpc3) shRNA, then it could be attributed to attenuation of I CAN in non-Dbx1 inhibitory neurons of the preBötC, but breath size always decreased after shRNA. Furthermore, only 35% of inhibitory preBötC neurons express Trpm4 [45] , and we show that 9-phenanthrol has no measurable effect on inspiratory and sigh bursts in glycinergic preBötC neurons. While we cannot conclude that shRNA knockdown in non-Dbx1 (presumably inhibitory) neurons has no effect on the preBötC, those effects are far less influential than shRNA knockdown in Dbx1 neurons, in which the preeminent role of Trpm4-mediated I CAN is to magnify inspiratory bursts, which directly impacts breath size. Thus, we conclude that Trpm4 knockdown reduces breath size by impeding I CANmediated burst generation in Dbx1 preBötC neurons.
Ion channels differentiate rhythm and pattern generation in a canonical CPG
Breathing is a canonical behavior whose underlying rhythm and motor pattern emanate from a central pattern generator (CPG) network [100] . Whereas rhythm and pattern CPG functions are conjoint in lower vertebrates, mammalian motor behaviors incorporate multiple discrete phases (for locomotion there are multiple limbs and joints), which require CPGs with separable constituent parts: rhythmogenic cores that set the frequency and motor-pattern microcircuits that govern the amplitude and phase of the ensemble movements [101] . The breathing CPG shows us that pattern-related function encroaches on the rhythmogenic core.
Dbx1 preBötC neurons are inspiratory rhythmogenic [1] , and some project to premotor and motor neurons [36, 38, 39, 102] . Our data can be parsimoniously explained by Trpm4 (and to a lesser extent Trpc3) reduction affecting burst size, hence the number of spikes in Dbx1 preBötC neurons sent to premotor and motor neurons, which ultimately diminishes inspiratory breathing movements.
However, a suitable explanation for the breathing changes induced by Trpm4 (and to a lesser extent Trpc3) shRNA should consider the effects across the entire population of Dbx1 preBötC interneurons, not just those projecting to premotor or motor neurons. In that regard, "burstlet" theory may provide a framework for interpretation: it posits that recurrent synaptic excitation is sufficient for rhythm generation but subthreshold for motor output [5, 6] . Burst generation largely attributable to Trpm4-mediated I CAN plays a crucial role by propagating rhythmic activity from the preBötC core oscillator, i.e., Dbx1 interneurons that only connect to one another and can generate rhythms without high-amplitude bursts, to pattern-related and premotor microcircuits extrinsic to the preBötC. Thus, we identify discrete sets of ion channels, predominantly Trpm4 but to a lesser extent Trpc3, whose role in rhythmogenic interneurons pertains specifically to pattern generation. Therefore, rhythm and pattern generating functionality may, to some extent, be shared in canonical classes of CPG interneurons, a principle that may be generally applicable to understanding the neural bases of motor behavior in mammals.
Materials and methods
Ethics statement
The For neuroanatomy or in vitro physiology experiments, neonatal mice were anesthetized by hypothermia and then killed by thoracic transection. Adult mice were killed via a lethal dose of pentobarbital (100 mg/kg body mass, IP). For in vivo injections, adult mice were anesthetized via ketamine (100 mg/kg, IP) and xylazine (10 mg/kg, IP).
Animals
Mice were housed in colony cages on a 14-hour light/10-hour dark cycle with controlled humidity and temperature at 23˚C, and were fed ad libitum on a normal rodent diet (Teklad Global Diets, Envigo, Madison, WI) with free access to water. At least three types of environmental enrichment materials were provided in each cage to improve the well-being of the mice.
For experiments pertaining to Dbx1 preBötC interneurons, we used knockin mice that express Cre recombinase fused to the tamoxifen-sensitive estrogen receptor Dbx1
CreERT2 [104] (IMSR Cat# JAX:028131, RRID:IMSR_JAX:028131) and floxed reporter mice with inducible expression of the red fluorescent protein variant tdTomato dubbed Ai9 by the Allen Institute for Brain Science [105] (IMSR Cat# JAX:007905, RRID:IMSR_JAX:007905). We crossed homozygous Dbx1 CreERT2 females with Ai9 males. We refer to their offspring as Dbx1;Ai9 mice. To achieve optimal tdTomato expression in Dbx1-derived neurons, we administered a 22.5 mg/kg dose of tamoxifen (Sigma Aldrich, St. Louis, MO) dissolved at a concentration of 10 mg/ml in corn oil by oral gavage to pregnant dams at embryonic day 9.5 [47] . Newborn Dbx1;Ai9 pups express tdTomato in Dbx1-derived neurons in the preBötC and contiguous regions of the medulla [106] . For experiments pertaining to glycinergic preBötC interneurons, we used transgenic mice that express eGFP under the control of the promoter for the glycine transporter 2 gene (slc6A5), i.e., GlyT2-eGFP mice [53] .
For anatomy or physiology experiments (see below), we used Dbx1;Ai9, GlyT2-eGFP, and wild-type CD-1 mice of both sexes at postnatal day 0 to 4 (P0-4). Dbx1
CreERT2 mice have a CD-1 genetic background. Ai9 and GlyT2-eGFP mice have a C57Bl/6 background. The anatomy of respiratory networks is well documented in the brainstem of P0-4 Dbx1;Ai9 (CD-1 background) and C57Bl/6 mice [107, 108] , so the relative position of respiratory nuclei, particularly the preBötC, is stable during postnatal development (P0-4) across mouse strains. Neonatal Dbx1;Ai9, GlyT2-eGFP, and wild-type CD-1 mice were anesthetized by hypothermia and then killed by thoracic transection. The neuraxis was removed in less than 2 min and further dissected in a dish filled with artificial cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl, 3 KCl, 1.5 CaCl 2 , 1 MgSO 4 , 25 NaHCO 3 , 0.5 NaH 2 PO 4 , and 30 dextrose equilibrated with 95% O 2 -5% CO 2 , pH 7.4.
Trpm4 and Trpc3 immunohistochemistry
The neuraxes of Dbx1;Ai9 pups were fixed in 4% paraformaldehyde (PFA) for 16-24 hours, rinsed in phosphate buffered saline (PBS) (BP399-1, Fisher Scientific, Hampton, NH), then immobilized in 4% agar for sectioning in the transverse plane. preBötC sections (50-100 μm thick) were incubated with 20% normal donkey serum (50-413-367, Fisher Scientific) overnight at 4˚C on an orbital shaker. The following day, sections were washed with PBS 2 x 30 min and were then incubated overnight in PBS with 0.4% TritonX-100 at 4˚C on an orbital shaker in the presence of primary antibodies. Those included (1) 1:250 rabbit polyclonal antiTrpm4 corresponding to amino acids 60-74 (NH2-TEWNSDEHTTEKPTDC-COOH) of the amino-terminal tail of rat Trpm4 with an added carboxyl-terminal cysteine [109] whose specificity was tested via western blot of protein extracted from cultured MCF-7 cells [110] as well as western blot and single-cell RT-PCR in mouse brain tissue by the authors (R. Teruyama); (2) 1:500 rabbit polyclonal anti-Trpc3 (ACC-016, RRID:AB_2040236, Alomone Labs, Jerusalem) whose specificity was verified using a Trpc3 knockout mouse [111] ; and (3) For immunohistochemistry in adults, Dbx1;Ai9 mice of both sexes all within the age range 10-14 weeks were transcardially perfused with PBS followed by 4% PFA. Neuraxes were removed and placed in 4% PFA overnight, rinsed with PBS, then immobilized in 4% agar for sectioning. Transverse preBötC sections (50-100 μm thick) were incubated in 1:250 rabbit anti-Trpm4, 1:400 rabbit anti-Trpc3, or 1:500 goat anti-GFAP in PBS with 0.4% TritonX-100 overnight at 4˚C on an orbital shaker. Sections were then washed 2 x 30 min with PBS and incubated with 20% normal donkey serum with 0.4% TritonX-100 for 90 min on an orbital shaker at room temperature. Then, after two 10-min washes, the sections were placed in 1:200 donkey anti-rabbit Alexa 647, 1:100 donkey anti-rabbit Alexa 405, or 1:200 donkey anti-goat Alexa 647 for 1 hour at room temperature. Sections were then washed for a minimum of 6 x 30 min in PBS.
All sections were mounted on glass slides and cover-slipped, and images were acquired with a 10x air (NA 0.45), 40x water immersion (NA 1.15), and 60x oil immersion (NA 1.49) objectives on a confocal microscope (Nikon, Melville, NY) and (Thorlabs, Newton, NJ).
shRNA constructs
Specific shRNA sequences designed to knockdown Trp transcripts (CCTAACTCACT-GATCCGAAAT for Trpm4, NCBI 68667, RefSeq NM_175130.4, and GAGGTTCAATATTT-CACCTATGC for Trpc3, NCBI 22065, RefSeq NM_019510.2) [112] were incorporated into a viral vector, which features a U6 polymerase III promoter to drive shRNA expression and a CMV promoter to drive eGFP expression for identification of transduced neurons (Cyagen Biosciences, Santa Clara, CA). We chose an AAV vector with serotype 9 to package the shRNA because AAV9 achieves high transduction of neurons, but not microglia or oligodendrocytes, in mouse brains [113] . We also used a nontargeting shRNA (CCTAAGGT-TAAGTCGCCCTCG), which is a randomized sequence from Trpm4 but has no homology to any known genes in mouse or human as a control. The standard titer of AAV is �1 x 10 13 GC/ ml (genome copies per ml).
In vivo AAV injections
Our group has been studying respiratory function of Dbx1-derived neurons for nine years using the Dbx1 CreERT2 mouse strain with a CD-1 background [37, 91, [114] [115] [116] [117] [118] [119] . Therefore, we used CD-1 mice for in vivo behavioral experiments. CD-1 mice of both sexes, all within the age range of 10-14 weeks, were anesthetized via ketamine (100 mg/kg, IP) and xylazine (10 mg/kg, IP) and positioned in a stereotaxic frame. We exposed the skull aseptically and drilled two holes with coordinates 6.9 to 7.8 mm caudal to bregma, 1.2 mm lateral to midline on both sides, at a dorsal-ventral depth of 5.2 mm from the brain surface. We injected 100 nl of virus into each hemisphere through a 30-gauge 2.0 μl Hamilton Neurosyringe (Hamilton Company, Reno, NV) at rate of 50 nl/min. The needle was left in place for an additional 5 min to allow for diffusion. The scalp was then stapled, and triple antibiotic cream containing neomycin, bacitracin, and polymyxin antibiotics was applied to the wound. The mice recovered on a heating pad and were closely monitored postoperatively for signs of infection, pain, or distress. Local antibiotics and ketoprofen (5 mg/kg) was administered on an as-needed basis. We periodically measured breathing behavior for 6 weeks before killing the mice to examine the extent of virus transduction and expression. Following transcardial perfusion and fixation, transverse sections of the medulla (75 μm thick) were examined for eGFP expression in the preBötC. The area of virus expression for all mice was quantified by superimposing confocal sections from individual mice onto corresponding sections from a mouse atlas [120] . Pixel intensity in unprocessed 12-bit confocal microscopy sections (4,096 values) was equally divided into low (0-2,048) and high (2,049-4,096) intensity levels. Low-intensity contours were plotted at 10% transparency; high-intensity contours were plotted at 20% transparency. The darkest area of coloration indicates the center of virus expression, while lightly colored areas indicating peripheral regions with lower expression.
ddPCR to measure Trp knockdown
In separate experiments to assess the effectiveness of shRNA knockdown of Trp transcripts, adult CD-1 mice of both sexes, all within the age range of 10-14 weeks, were injected with 200 nl of AAV containing either Trpm4-targeted shRNA or Trpc3-targeted shRNA in the left preBötC and a nontargeting control sequence in the right preBötC. Three animals were tested (i.e., three biological replicates) in each group targeting either Trpm4 or Trpc3 (n = 6 mice total). Each animal served as its own control because the left preBötC was injected with either Trpm4 or Trpc3 shRNA, and the right preBötC was injected with control shRNA containing a randomized sequence without a known gene target. After 5 weeks of incubation, the adult mice were rapidly killed, and the bilateral halves of the preBötC region were isolated and separated to extract RNA that was reversed transcribed to cDNA and then processed to quantify gene expression. Briefly, total RNA was extracted using RNAzol RT (RN 190, Molecular Research, Cincinnati, OH) and further purified with 4-bromoanisole (BAN) to eliminate contaminating DNA. RNA was normalized to 500 ng across all samples and then reversed transcribed to cDNA using the iScript Reverse Transcription Supermix for RT-qPCR (1708840, Bio-Rad, Hercules, CA). RNA and cDNA concentration and quality were measured using NanoDrop One Microvolume UV-VIS Spectrophotometer (ND-ONE-W, Thermo Fisher Scientific, Waltham, MA). We used a final concentration of 2.5 ng/μl cDNA to quantify Trpm4 and Trpc3 via droplet digital PCR (i.e., ddPCR) (QX100, Bio-Rad), which partitions samples into thousands of droplets then amplified by PCR using Taqman Gene Expression Assays (Trpm4: TCTTGTGAAAGCCTGTGG-GAGCTCT, Mm00613173_m1, RefSeq NM_175130.4; or Trpc3: CCTTGTAGCAGGCTGGGGAAGATTC, Mm00444690_m1, RefSeq NM_019510.2; 4331182, Life Technologies, Carlsbad, CA). The hydrolysis primers and probes in the Taqman assays were designed to span exon-exon junctions to avoid amplifying the target from genomic DNA, if present. Following PCR amplification, the Quantasoft software v1.7.4 (Bio-Rad) analyzed the number of positive (containing at least one copy of the target) and negative droplets. Absolute copy number of transcripts per μl of cDNA was determined by fitting the fraction of positive droplets to a Poisson distribution. A no-template control and a negative control from the reverse transcription reaction of selected samples were also included in the ddPCR assay, which returned a zero count, as expected.
Western blot to analyze protein knockdown
Adult CD-1 mice of both sexes, all within the age range of 10-14 weeks, were injected with 100 nl of AAV containing either Trpm4-targeted shRNA (n = 12) or Trpc3-targeted shRNA (n = 12) in the left preBötC and a nontargeting control sequence in the right preBötC. Three mice from each group were rapidly killed at each time point (day 10, 20, 30, or 40 postinjection), and the bilateral halves of the preBötC region were dissected for protein extraction. Brain tissues containing the preBötC were homogenized and sonicated in 500 μl cold lysis buffer (Cell Signaling Technology, Danvers, MA) containing 1 mM protease inhibitor phenylmethylsulfonyl fluoride (PMSF) added immediately before use. After centrifugation of brain lysates at 16,000 x g for 15 min, crude total protein concentrations of the supernatants were determined using Nanodrop One Spectrophotometer A280 analysis (Thermo Fisher Scientific).
Approximately 80 μg of total protein was resolved in 4%-12% gradient gels (NP0321, Thermo Fisher Scientific) and transferred onto polyvinylidene difluoride membrane. After blocking with OneBlock Western (20-314, Genesee Scientific, San Diego, CA) for 1 hour at room temperature, membranes were probed with primary antibodies against either Trpm4 (1:200) or Trpc3 (1:250) and the loading control beta-actin (1:1000, Abcam Cat# ab8224, RRID:AB 449644), followed by 1:15,000 polyclonal secondary antibodies IRDye 680RD goat anti-rabbit (LI-COR Biosciences Cat# 925-68071, RRID:AB_2721181) or IRDye 800CW goat anti-mouse (LI-COR Biosciences Cat# P/N 925-32210, RRID:AB_2687825). Both primary and secondary antibodies were diluted in the blocking buffer. Washes after primary and secondary antibody incubations were done with 1x TBS with 0.1% Tween-20 for a minimum of 3 x 10 min. Immunoblot signals were captured and quantified using Odyssey CLx Infrared Imaging System (Li-Cor Biosciences, Lincoln, NE).
Breathing measurements: Whole-body plethysmography
We measured breathing behavior in unrestrained, awake adult CD-1 mice of both sexes, all within the age range of 10-14 weeks (n = 26 mice total), using a whole-body plethysmograph (EMKA Technologies, Falls Church, VA) with a flow rate of 1 l/min in normoxia (21% O 2 and 79% N 2 ). The airflow traces were analyzed using the spirometry module in LabChart 7 software (AD Instruments, Colorado Springs, CO). We measured V T , T I , and breathing rate (frequency). MV was calculated by multiplying the V T and frequency. The mice were introduced to the plethysmograph 1 week prior to AAV injection via three 30-min sessions inside the chamber, the first with a lightly closed but unsealed chamber, and the final two sessions with a sealed chamber and balanced airflow conditions. Those acclimatization sessions were not analyzed. For analyses, we performed plethysmography before shRNA injection (day 0), which we define as baseline breathing, and then intermittently for 6 weeks. Mice were recorded in 2 continuous 30-min sessions every 6 days. The day of each recording session is indicated by x-axis in Fig 6 . The mice were placed in the sealed chamber with balanced air flow 10 min prior to data collection during each session for acclimatization. Human experimenters observed the mice firsthand during every session. The mice were alert to their environment, which is consistent with wakefulness. Locomotion, grooming, and sniffing (with synchronized whisking) entrain and modify breathing [1, [121] [122] [123] , so we only analyzed epochs of calm breathing absent other orofacial or motor behaviors (e.g., Fig 4) . Epochs of calm breathing represent eupnea. The sum of the duration of epochs of eupnea always exceeded 2 min for each 30 min session. Sighs, which are periodic large magnitude augmented inspiratory efforts [106] , could be distinguished by inhaled volume exceeding V T by 2-3-fold (the inspired air during a sigh draws on the "inspiratory reserve volume" of the lungs, and thus exceeds V T by definition). We excluded sighs from the analyses whenever they were embedded within an epoch of eupnea. Excluding sighs was important because of their large volume and because of the prolonged pause that follows each sigh; both of which confound measurements of V T , T I , and frequency. Gasps can be distinguished from sighs based on their rise time being approximately half as long and because an active exhale precedes a gasp. We also excluded gasps from analyses of eupnea.
We nonetheless counted the number of sighs within the 30-min recording period to compute sigh frequency. However, we could not accurately compute sigh volume or duration because sighs occurred during all behavioral states (locomotion, grooming, sniffing, as well as eupnea) and attempting to measure sigh volume and duration in other behavioral states yields inaccuracies due to fluctuations that obscure functional residual capacity, i.e., equilibrium lung volume and variable respiratory demand. There is no MV pertaining to sighs because they are episodic events interspersed among eupneic breaths, not continuous.
Breathing-related measurements in vitro: Brainstem slices and electrophysiology
Isolated neuraxes from Dbx1;Ai9, GlyT2-eGFP, and CD-1 wild-type neonatal mice (0-4) of both sexes were fixed to an agar block and then cut in the transverse plane to obtain a single 550-μm-thick slice that exposes the preBötC at its rostral face [106] . Slices were then perfused with aCSF at 28˚C in a recording chamber on a fixed-stage microscope with epifluorescence to visually identify tdTomato-or eGFP-expressing target neurons. Extracellular K + was increased to 9 mM to elevate preBötC excitability [72] . Inspiratory-related motor output was recorded from the XII, which are captured in transverse slices, using suction electrodes and a differential amplifier. We also simultaneously recorded field potentials from the preBötC. Amplifier gain was set at 2,000, and the band-pass filter was set at 300-1,000 Hz. XII and preBötC bursts were full-wave rectified and smoothed for display.
We obtained whole-cell patch-clamp recordings under visual control using pipettes with resistance of 4-6 MO and a Dagan IX2-700 current-clamp amplifier (Minneapolis, MN), an EPC-10 patch-clamp amplifier in current-clamp mode (HEKA Instruments, Holliston, MA), or a Molecular Devices Multiclamp 700B patch-clamp amplifier in current clamp mode (San Jose, CA). All recordings were digitally acquired at 4 kHz using after 1 kHz low-pass filtering.
The patch-pipette solution contained (in mM) 140 K-Gluconate, 10 HEPES, 5 NaCl, 1 MgCl 2 , 0.1 EGTA, 2 Mg-ATP, and 0.3 Na(3)-GTP. We added 50 μM of Alexa 488 hydrazide dye (A10436, Life Technologies) to the patch solution for nonred fluorescent visualization of Dbx1 preBötC interneurons recorded in the whole-cell configuration.
We measured the area and amplitude of preBötC field potentials and inspiratory drive potentials, respectively, after digital smoothing. In the case of inspiratory drive potentials, smoothing eliminates spikes but preserves the underlying envelope of depolarization of the inspiratory drive potential [124] . We also measured the amplitude and area of low-frequency sighs (<0.01 Hz), i.e., augmented bursts with two peaks (doublet) that typically have a greater amplitude and often double the area of normal inspiratory bursts [73] [74] [75] .
Pharmacology
The Trpm4 antagonist 9-phenanthrol [50] (211281, Sigma) (10, 50, 100, and 200 μM) and Trpc3 antagonist pyrazole-3 (pyr-3) [51, 52] (P0032, Sigma) (1, 10, and 50 µM) were bathapplied while monitoring field potentials in the preBötC and XII motor output. We applied BAPTA (30 mM), FFA (100 μM), and 9-phenanthrol (100 μM) via dialysis through the patch pipette to test their effects on individual Dbx1 preBötC neurons without attendant network effects. Pyr-3 (10 μM) is only effective when applied extracellularly [51, 52] .
Statistics
We plotted V T , frequency, T I , and MV versus day post-shRNA injection and then performed linear regression analyses to obtain the best-fit slope (Prism, Graphpad Software, La Jolla, CA). Each individual measurement, rather than the mean value for each day post-shRNA, was considered a separate point in the analysis. We report the goodness of fit (r 2 ) along with the 95% confidence interval. We applied an F test to evaluate the slope of the relationships of V T , frequency, T I , and MV versus day post-shRNA. Assuming there is no relationship, i.e., slope is zero, then the F statistic returns a P value quantifying the likelihood of obtaining a slope deviating from zero. We used orthodox criteria (alpha of 0.05) to judge whether a slope was significantly nonzero and thus that a trend exists for V T , frequency, T I , or MV versus day postshRNA. For the electrophysiology data, we used paired t tests to compare measurements between control and drug. Data are reported as mean ± SD. Group data quantifying inspiratory (left) and sigh (right) bursts at the onset of whole-cell recording (t0) and at ss (following approximately 20 min of drug exposure) for both Trp channel antagonists, 9-phenanthrol (top row) and pyr-3 (bottom row). All of these data are from neonatal GlyT2-eGFP mice. Means and SD bars (magenta) are shown with raw data from each glycinergic neuron recorded. We detected no significant effects. Primary data can be found in the Supporting information (S1 Data). GlyT2, glycine transporter 2; eGFP, enhanced green fluorescent protein; preBötC, pre-Bötzinger complex; pyr-3, pyrazole- 
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